NasdaqCM - Delayed Quote USD
Immunome, Inc. (IMNM)
8.52
+0.02
+(0.24%)
At close: 4:00:00 PM EDT
8.52
0.00
(0.00%)
After hours: 4:02:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-110,794
-110,794
-7,568
-28,690
-18,226
Investing Cash Flow
-85,063
-85,063
-30,484
-248
-79
Financing Cash Flow
240,529
240,529
116,408
32
27,768
End Cash Position
143,451
143,451
98,779
20,423
49,329
Interest Paid Supplemental Data
--
--
--
--
14
Capital Expenditure
-53,508
-53,508
-831
-248
-79
Issuance of Capital Stock
250,002
250,002
125,034
--
27,225
Repayment of Debt
-16
--
--
--
-113
Free Cash Flow
-164,302
-164,302
-8,399
-28,938
-18,305
12/31/2021 - 10/2/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SWTX SpringWorks Therapeutics, Inc.
44.93
+9.03%
IMNN Imunon, Inc.
0.8962
-0.20%
COGT Cogent Biosciences, Inc.
4.5100
+0.89%
JANX Janux Therapeutics, Inc.
32.07
+1.42%
TRML Tourmaline Bio, Inc.
17.32
-2.81%
KURA Kura Oncology, Inc.
6.43
+0.94%
APLS Apellis Pharmaceuticals, Inc.
17.54
+0.29%
AKRO Akero Therapeutics, Inc.
40.99
+3.48%
IMVT Immunovant, Inc.
15.07
+4.29%
BCYC Bicycle Therapeutics plc
8.60
-0.81%